Agency Forms Undergoing Paperwork Reduction Act Review, 27065-27066 [2012-11096]
Download as PDF
<![CDATA[
27065
Federal Register / Vol. 77, No. 89 / Tuesday, May 8, 2012 / Notices
them to be critical users in their
approach and application of the data.
Similar methodology has been
adopted by other federal agencies, as
well as by academic and commercial
survey organizations. There are no costs
to respondents other than their time.
The total estimated annual burden
hours are 9450.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Projects
QDRL Interviews ..............................................................................................................
Focus groups ...................................................................................................................
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012–11086 Filed 5–7–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–12–0828]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
National Adult Tobacco Survey
(NATS)—Reinstatement with Changes—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC) and the Center for
Tobacco Products (CTP), Food and Drug
Administration (FDA).
srobinson on DSK4SPTVN1PROD with NOTICES
Background and Brief Description
Tobacco use remains the leading
preventable cause of disease and death
in the United States, resulting in
approximately 440,000 deaths annually.
VerDate Mar<15>2010
17:33 May 07, 2012
Jkt 226001
Smokers die an average of 14 years
earlier than nonsmokers. Moreover,
cigarette smoking costs more than $193
billion; $97 billion in lost productivity
plus $96 billion in health care
expenditures.
With passage of the Family Smoking
Prevention and Tobacco Control Act
(Tobacco Control Act) in 2009, the FDA
is legally mandated to regulate tobacco
products for the protection of public
health. Such authority involves
considering whether the marketing of
tobacco products might encourage
people who don’t use tobacco products
to begin using them, to encourage
people who might otherwise quit to
continue using tobacco, or to encourage
former users to relapse.
In order to ensure that FDA is in
compliance with the Tobacco Control
Act’s mandate to protect the public
health, annual data collection is needed
at least initially to monitor the benefits
and potential adverse consequences of
FDA’s regulatory actions, as the
regulatory framework is being
established. As novel tobacco products
are introduced onto the market, the FDA
must regularly monitor patterns of all
tobacco product usage—not just
cigarettes—to identify changes in
susceptibility and rates of tobacco use
initiation, perceptions regarding tobacco
use, and rates of tobacco use cessation.
Rather than develop a completely new
system to monitor measures critical to
FDA, and thereby increasing burden to
the population, FDA has partnered with
CDC to leverage the existing NATS
system. While NATS has been redesigned to meet the critical data needs
of the FDA, many of the measures are
relevant to CDC’s National Tobacco
Control Program (NTCP), and CDC also
will use the NATS data to evaluate the
NTCP. Many of the NATS questions
reflect CDC’s key outcome indicators for
evaluating tobacco control programs.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Responses per
respondent
9000
300
1
1
Average burden
per response
(in hours)
1
1.5
CDC proposes to conduct three annual
cycles of the NATS to collect data
necessary to evaluate the effectiveness
of FDA’s initial regulatory actions. The
NATS will be a stratified, random-digit
dialed telephone survey of noninstitutionalized adults 18 years of age
and older. To yield results that are
representative nationally, information
will be collected from 56,250 landline
respondents and 18,750 cell phone
respondents who do not have a landline
to include the growing population of
households that exclusively use cell
phones and would be missed in a
survey relying only on land-lines. To
obtain the target number of completed
telephone interviews, approximately
166,000 respondents will be contacted
for initial eligibility screening and
consent.
The burden per response for the
proposed NATS remains the same by
design as the 2009/2010 NATS.
However, the number of respondents is
smaller because the current NATS seeks
to develop national estimates, whereas
the 2009/2010 NATS sought to develop
state-level estimates. Therefore, the total
respondent burden for the new NATS
cycle is substantially lower than the
prior NATS. The 2009/2010 NATS
involved a total respondent burden of
38,303 hours. The revised 2012/2013
NATS involves a total respondent
burden of 29,850 hours, which amounts
to 8,453 fewer hours, or 22.1% fewer
hours, than the 2009/2010 NATS.
Results will have significant
implications for the development and
periodic adjustment of policies and
programs aimed at preventing and
reducing tobacco use in the United
States.
Participation in the NATS is
voluntary. There are no costs to
respondents except their time. The total
estimated annualized burden hours are
29,850.
E:\FR\FM\08MYN1.SGM
08MYN1
27066
Federal Register / Vol. 77, No. 89 / Tuesday, May 8, 2012 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Adults ages 18 or older ..........
Screener for land-line users (pp. 3–8 of the NATS) ..............
Screener for cell phone users (pp. 9–11 of the NATS) .........
National Adult Tobacco Survey for landline users (pp. 12–
end of the NATS).
National Adult Tobacco Survey for cell phone users (pp.
12–end of the NATS).
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012–11096 Filed 5–7–12; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
[60Day–12–12JF]
srobinson on DSK4SPTVN1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Kimberly Lane, at
CDC, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an email to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
17:33 May 07, 2012
Jkt 226001
Returning our Veterans to
Employment and Reintegration
(ROVER)-New-National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Mar<15>2010
Proposed Project
NIOSH, under Public Law 91–596,
Sections 20 and 22 (Section 20–22,
Occupational Safety and Health Act of
1970) has the responsibility to conduct
research relating to innovative methods,
techniques, and approaches dealing
with occupational safety and health
problems.
Reintegrating Post-9/11 Veterans into
civilian life and employment is
complicated by recent exposure to war
zone stressors (e.g., combat, bombs,
improvised explosive devices, injury
and death of military personnel and
civilians) and development of clinical
disorders, such as posttraumatic stress
disorder (PTSD) and depression. PTSD,
for example, is typified by such
symptoms as re-experiencing war zone
stressors (e.g., distracting intrusive
thoughts and images, disturbing
nightmares); hyper-arousal (e.g., intense
startle response, poor concentration and
memory, constantly being on-guard,
disturbed sleep, high irritability); and
avoidance of people (family, friends, coworkers), places (such as enclosed areas,
crowds), and things (e.g., loud noises,
certain sights and smells) that remind
one of war zone stressors. Such
symptoms can have a significant impact
on the ability of a Veteran to work in a
setting with features such as other
people, enclosed work areas, constant
movement and noise, tasks that require
concentration to details or safety issues,
and stress related to requests and
feedback of supervisors or task speed
and accuracy. An approach for helping
Veterans with PTSD and other
psychiatric impairments is that of using
service dogs for assistance and support.
Although there is significant interest
in service dogs for Veterans to aid in
readjustment, the focus has not been on
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
125,000
41,000
56,250
1
1
1
2/60
1/60
20/60
18,750
1
20/60
employment. Although a service-dog
program ‘‘feels good’’ and has face
validity, there is a resounding lack of
empirical evidence documenting
whether the provision of service dogs is
of therapeutic benefit for persons with
PTSD—other than the generally
accepted positive effects of humananimal companionship. For example, a
descriptive review of the pet-facilitated
therapy (PFT) literature by Brodie and
Biley (1999) presages a more substantive
review by Nimer and Lundahl (2007) in
finding multiple studies with poor
research designs and other
methodological problems that made it
hard for those authors to draw firm
conclusions. Even where studies
focused on ‘‘psychological’’ outcomes,
these tended to be self-report measures
of such constructs as stress, relaxation,
loneliness, and morale. Some impact on
the behavior of children was noted;
standard measures of clinical disorders
(e.g., depression, anxiety) were not
noted.
Nimar and Lundahl (2007) conducted
a meta-analysis of the animal-assisted
therapy (AAT) literature; that is, studies
examining the incorporation of animals
in treatment plans. Over 250 studies
were located, but only 49 (20%) met the
criteria of sufficient statistical
information to estimate effect sizes.
Most of the studies utilized dogs with
children with behavior problems or
developmental disorders, or adults with
chronic mental disorders, such as
dementia or schizophrenia. None of the
studies specifically included Veterans,
and none focused on the work setting
(although several looked at animals as
an adjunct to occupational therapy). The
overall effect size for the impact of AAT
was considered to be ‘‘moderate,’’ with
no differential effects related to the
population receiving AAT—a positive
point when considering extending this
work to Veterans. Most of the outcomes
were focused on emotional well-being,
but there were positive findings for an
impact on behavioral problems (mostly
with children). In general, the literature
is problematic for the lack of
E:\FR\FM\08MYN1.SGM
08MYN1
]]>Agencies
[Federal Register Volume 77, Number 89 (Tuesday, May 8, 2012)]
[Notices]
[Pages 27065-27066]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-11096]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-12-0828]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-7570 or send an email to
omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-5806.
Written comments should be received within 30 days of this notice.
Proposed Project
National Adult Tobacco Survey (NATS)--Reinstatement with Changes--
National Center for Chronic Disease Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control and Prevention (CDC) and the
Center for Tobacco Products (CTP), Food and Drug Administration (FDA).
Background and Brief Description
Tobacco use remains the leading preventable cause of disease and
death in the United States, resulting in approximately 440,000 deaths
annually. Smokers die an average of 14 years earlier than nonsmokers.
Moreover, cigarette smoking costs more than $193 billion; $97 billion
in lost productivity plus $96 billion in health care expenditures.
With passage of the Family Smoking Prevention and Tobacco Control
Act (Tobacco Control Act) in 2009, the FDA is legally mandated to
regulate tobacco products for the protection of public health. Such
authority involves considering whether the marketing of tobacco
products might encourage people who don't use tobacco products to begin
using them, to encourage people who might otherwise quit to continue
using tobacco, or to encourage former users to relapse.
In order to ensure that FDA is in compliance with the Tobacco
Control Act's mandate to protect the public health, annual data
collection is needed at least initially to monitor the benefits and
potential adverse consequences of FDA's regulatory actions, as the
regulatory framework is being established. As novel tobacco products
are introduced onto the market, the FDA must regularly monitor patterns
of all tobacco product usage--not just cigarettes--to identify changes
in susceptibility and rates of tobacco use initiation, perceptions
regarding tobacco use, and rates of tobacco use cessation.
Rather than develop a completely new system to monitor measures
critical to FDA, and thereby increasing burden to the population, FDA
has partnered with CDC to leverage the existing NATS system. While NATS
has been re-designed to meet the critical data needs of the FDA, many
of the measures are relevant to CDC's National Tobacco Control Program
(NTCP), and CDC also will use the NATS data to evaluate the NTCP. Many
of the NATS questions reflect CDC's key outcome indicators for
evaluating tobacco control programs.
CDC proposes to conduct three annual cycles of the NATS to collect
data necessary to evaluate the effectiveness of FDA's initial
regulatory actions. The NATS will be a stratified, random-digit dialed
telephone survey of non-institutionalized adults 18 years of age and
older. To yield results that are representative nationally, information
will be collected from 56,250 landline respondents and 18,750 cell
phone respondents who do not have a landline to include the growing
population of households that exclusively use cell phones and would be
missed in a survey relying only on land-lines. To obtain the target
number of completed telephone interviews, approximately 166,000
respondents will be contacted for initial eligibility screening and
consent.
The burden per response for the proposed NATS remains the same by
design as the 2009/2010 NATS. However, the number of respondents is
smaller because the current NATS seeks to develop national estimates,
whereas the 2009/2010 NATS sought to develop state-level estimates.
Therefore, the total respondent burden for the new NATS cycle is
substantially lower than the prior NATS. The 2009/2010 NATS involved a
total respondent burden of 38,303 hours. The revised 2012/2013 NATS
involves a total respondent burden of 29,850 hours, which amounts to
8,453 fewer hours, or 22.1% fewer hours, than the 2009/2010 NATS.
Results will have significant implications for the development and
periodic adjustment of policies and programs aimed at preventing and
reducing tobacco use in the United States.
Participation in the NATS is voluntary. There are no costs to
respondents except their time. The total estimated annualized burden
hours are 29,850.
[[Page 27066]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Adults ages 18 or older............ Screener for land-line 125,000 1 2/60
users (pp. 3-8 of the
NATS).
Screener for cell phone 41,000 1 1/60
users (pp. 9-11 of the
NATS).
National Adult Tobacco 56,250 1 20/60
Survey for landline users
(pp. 12-end of the NATS).
National Adult Tobacco 18,750 1 20/60
Survey for cell phone
users (pp. 12-end of the
NATS).
----------------------------------------------------------------------------------------------------------------
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012-11096 Filed 5-7-12; 8:45 am]
BILLING CODE 4163-18-P
